Gng2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GNG2 is a protein that plays a critical role in neurodegenerative disease. It is located on chromosome 14q21.3 and catalogued as NCBI Gene ID 63928. [1]
GNG2 is a G protein subunit involved in neuronal signaling. It plays a role in synaptic transmission and is implicated in neuropsychiatric disorders. [2]
--- [3]
GNG2 encodes the G protein subunit gamma 2 (Gγ2), a component of heterotrimeric G protein complexes essential for cellular signal transduction in the nervous system. [4]
| Attribute | Value |
|---|---|
| Protein Name | G Protein Subunit Gamma 2 |
| Gene | GNG2 |
| UniProt ID | P59768 |
| Molecular Weight | ~8 kDa |
| Subcellular Localization | Cytoplasm, plasma membrane (as Gβγ dimer) |
| Protein Family | G protein γ subunit family |
Gγ2 is a small protein (~71 amino acids) that forms a stable heterodimer with Gβ subunits through a coiled-coil interaction. The Gβγ dimer then associates with Gα subunits to form functional heterotrimers. Gγ2 contains an isoprenylation site at the C-terminus (CaaX motif) that is essential for membrane localization.
Gβγ complexes formed with Gγ2 modulate multiple effector systems:
In neurons, Gβγ signaling regulates synaptic transmission, neuronal excitability, and plasticity.
Alzheimer's Disease: Altered Gβγ signaling affects hippocampal synaptic plasticity and memory formation. Aβ oligomers disrupt G protein coupling in neurons.
Parkinson's Disease: Dysregulated G protein signaling in dopaminergic neurons affects survival and function. Gβγ modulators may have neuroprotective potential.
Schizophrenia: Altered G protein signaling affects neurotransmission through dopamine, serotonin, and glutamate receptors.
Gβγ signaling modulators are being developed for:
The study of Gng2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Expression data for GNG2 in the human brain can be explored through the following Allen Brain Atlas resources: